{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-026239","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2022-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.762523+00:00","generated_at":"2026-06-21T07:26:35.773073+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Arcadia creates Series A Preferred with voting rights on reverse stock split; quorum lowered to one-third","bullets":["Declared dividend of 1/1000th share of Series A Preferred per common share; record date Dec 28, 2022, distribution Dec 29, 2022.","Each 1/1000th of Series A Preferred carries 1,000 votes, but only on proposals for a reverse stock split and adjournment.","Preferred shares are not transferable except with transfer of common shares; voting automatically mirrors common share vote.","Bylaws amended to reduce stockholder meeting quorum from majority to one-third of voting power.","Unredeemed preferred shares redeemed after meeting for $0.10 per 100 shares (subject to conditions); odd lots may receive no cash."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-026239","json":"https://secwatch.observer/filing/0000950170-22-026239.json","markdown":"https://secwatch.observer/filing/0000950170-22-026239.md","text":"https://secwatch.observer/filing/0000950170-22-026239.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022026239/0000950170-22-026239-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022026239/rkda-20221207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T07:26:35.773073+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}